ScholarLens Back to search
2001•GastroenterologyRequires access

Effects of CYP2C19 gene polymorphism on cure rates for Helicebacter pylori infection by triple therapy with proton pump inhibitor (omeprazole or rabeprazole), amoxicillin, and clarithromycin

Manabu Dojo, Takeshi Azuma, Masahiro Ohtani, Atsushi Muramatsu, Hiroyuki Suto, Yoshiyuki Ito, Masaru Kuriyama

Open publisher page 2 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Clarithromycin, Amoxicillin, Omeprazole, Azithromycin, CYP2C19, Rabeprazole, Proton-pump inhibitor, Helicobacter pylori

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
Effects of CYP2C19 gene polymorphism on cure rates for Helicebacter pylori infection by triple therapy with proton pump inhibitor (omeprazole or rabeprazole), amoxicillin, and clarithromycin — Research Paper | ScholarLens